Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Quarterly results
Acq. announced
Appointed director
TherapeuticsMD, Inc. (TXMD) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 4 ZIEGLER JOSEPH (Principal Financial Officer) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Granted 7,500 shares @ $0
08/21/2023 3 ZIEGLER JOSEPH (Principal Financial Officer) has filed a Form 3 on TherapeuticsMD, Inc.
08/18/2023 8-K Quarterly results
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "FORM 8-K",
"TherapeuticsMD Announces Second Quarter 2023 Financial Results"
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/10/2023 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
Docs: "FORM 8-K",
"Letter of Grant Thornton LLP"
07/06/2023 8-K Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial ...
Docs: "Fourth Amendment to Bylaws of the Company"
06/30/2023 SC 13D/A Rubric Capital Management LP reports a 19.6% stake in TherapeuticsMD, Inc.
06/29/2023 4 Rubric Capital Management LP (10% Owner) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Granted 312,525 shares @ $3.6797, valued at $1.1M
05/17/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/17/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/05/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/04/2023 4/A Walker Marlan D (CEO) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Sold 692 shares @ $3.6381, valued at $2.5k
Exercised 1,010 restricted stock units @ $0
Exercised 1,734 restricted stock units @ $0
05/01/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
05/01/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/21/2023 8-K Quarterly results
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/31/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
02/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Amendment, to the Employment Agreement, as extended effective October 15, 2021, by and between TherapeuticsMD, Inc. and Marlan Walker",
"General Consulting and Services Agreement by and between TherapeuticsMD, Inc. and MCD Consulting Management Services, LLC"
02/23/2023 4 Walker Marlan D (CEO) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Granted 70,000 restricted stock units @ $0
02/23/2023 4 Donegan Michael C (Prin. Fin. and Acctg. Officer) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Granted 50,000 restricted stock units @ $0
02/22/2023 4/A Rubric Capital Management LP (10% Owner) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Disposed/sold 29,000 shares @ $1333, valued at $38.7M
02/13/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/30/2023 4 Donegan Michael C (Prin. Fin. and Acctg. Officer) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Sold 1,648 shares @ $5.0796, valued at $8.4k
Sold 49 shares @ $5.09, valued at $249.4
Exercised 2,400 rights @ $0
Exercised 1,140 rights @ $0
01/25/2023 4 Donegan Michael C (Prin. Fin. and Acctg. Officer) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Sold 1,302 shares @ $5.3383, valued at $7k
Sold 7 shares @ $5.3101, valued at $37.2
Exercised 380 restricted stock units @ $0
Exercised 1,066 restricted stock units @ $0
Exercised 519 restricted stock units @ $0
Exercised 2,400 restricted stock units @ $0
01/18/2023 8-K Quarterly results
01/12/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
01/06/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Pro Forma Financial Statements with Respect to the Transformation of the Company"
01/03/2023 4 Rubric Capital Management LP (10% Owner) has filed a Form 4 on TherapeuticsMD, Inc.
Txns: Sold 29,000 shares @ $1333, valued at $38.7M
01/03/2023 8-K Resignation/termination of a director
Docs: "TherapeuticsMD Completes Transaction to License its Products to Mayne Pharma"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy